Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A pilot study on the formulation of topical methotrexate was conducted. Patients after baseline evaluation were randomly placed into either topical 1% methotrexate gel or clobetasol propionate 0.05% ointment which was applied for 6 weeks. PASI score was assessed at two-week intervals for a total of eight weeks. Blood chemistry parameters, whole abdomen ultrasound, and adverse drug reactions while on treatment and after eight weeks were monitored as secondary outcome measures.
Epistemonikos ID: dc574e8fdc66fd38249e71dd9fdf9824b11eb5fd
First added on: Sep 01, 2024